WASHINGTON – Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump announced Tuesday at the White House alongside Pfizer CEO Albert Bourla. Trump promised similar deals with other drugmakers facing a threat of tariffs.

The announcement came as the Republican president has spent months seeking to lower drug costs and as Washington faced a federal government shutdown amid a standoff between Democrats and Republicans over health care costs.

Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. This involves matching the lowest price offered in other developed nations.

“I can’t tell you how big this is,” the president sa

See Full Page